A randomized, double-blind, placebo-controlled cross-over study of epicutaneous immunotherapy for food allergy.
Not Applicable
- Conditions
- Food allergy
- Registration Number
- JPRN-UMIN000033049
- Lead Sponsor
- Department of Pediatrics, Hachioji Hospital, Faculty of Medicine, Tokai University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 13
Inclusion Criteria
Not provided
Exclusion Criteria
children without food Allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effects of epicutaneous immunotherapy were evaluated according to the cumulative tolerated dose in an oral food challenge.
- Secondary Outcome Measures
Name Time Method